Lets keep an eye on ITCI -
Intra-Cellular Therapies (ITCI)
$65.32 +5.03 8.34%
Intra-Cellular stock is breaking out past a cup with handle's buy point of 63.93, according to IBD MarketSmith chart analysis. ITCI stock reversed 0.5% lower midday Wednesday, but it remained in buy range above the...